MULTIPLE MYLEOMA

Clinical trials for MULTIPLE MYLEOMA explained in plain language.

Never miss a new study

Get alerted when new MULTIPLE MYLEOMA trials appear

Sign up with your email to follow new studies for MULTIPLE MYLEOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New universal CAR-T therapy targets tough blood cancer

Disease control Terminated

This early-phase study tests a new type of CAR-T cell therapy (UWD-00B) for people with multiple myeloma that has come back or not responded to other treatments. The therapy uses donor cells designed to attack a protein called BCMA on cancer cells. The main goals are to check saf…

Matched conditions: MULTIPLE MYLEOMA

Phase: EARLY_PHASE1 • Sponsor: Wondercel Biotech (ShenZhen) • Aim: Disease control

Last updated May 26, 2026 12:00 UTC

MULTIPLE MYLEOMA

Get alerted when new MULTIPLE MYLEOMA trials appear

New universal CAR-T therapy targets tough blood cancer